Enhance your understanding of hypertriglyceridemia with practical strategies to identify risk, evaluate underlying causes, and apply current and emerging therapies. Learn how multidisciplinary care can improve outcomes in complex patients.
Accreditation Statement
In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page.
Joint Accreditation Statement:
In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
MOC:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Credit Designation Statement:
Physicians:
The ACCF designates this internet enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses:
The ACCF designates this educational activity for a maximum of 1.5 continuing nursing education contact hours.
Physician Associates:
AAPA Credit Designation Statement – Enduring Materials
The American College of Cardiology Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until 04/30/2027 PAs should only claim credit commensurate with the extent of their participation.
Interprofessional Continuing Education (ICPE) Credit:
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
Target Audience:
This course is intended for physicians, nurses, physician associates and the cardiovascular care team.
Important Dates:
Date of Release: April 30, 2026
Term of Approval/Date of Expiration: April 30, 2027
Learner Objectives:
Upon completion, participants should be able to:
- Identify the clinical spectrum of HTG encompassing cardiometabolic risk and therapeutic approaches.
- Describe multifactorial causes of sHTG and FCS including genetic, medical, drug, and dietary factors.
- Describe new treatments for sHTG & FCS that may reduce associated complications, including pancreatitis.
- Apply current and emerging therapies within a multidisciplinary care pathway to improve patient outcomes.
Grant Acknowledgement:
Educational grant support for this activity provided by Ionis Pharmaceuticals.
Chair
Michael Miller, MD, FACC
Planning Committee
Alan S. Brown, MD, FACC
Viet T. Le, PA-C, DMSc, MPAS, FACC
Nicholas A. Marston, MD, MPH